story of the week
Early Treatment Effects of Fluvoxamine on COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Global Health
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
Lancet Glob Health 2021 Oct 27;[EPub Ahead of Print], G Reis, EA Dos Santos Moreira-Silva, DCM Silva, L Thabane, AC Milagres, TS Ferreira, CVQ Dos Santos, VH de Souza Campos, AMR Nogueira, APFG de Almeida, ED Callegari, AD de Figueiredo Neto, LCM Savassi, MIC Simplicio, LB Ribeiro, R Oliveira, O Harari, JI Forrest, H Ruton, S Sprague, P McKay, AV Glushchenko, CR Rayner, EJ Lenze, AM Reiersen, GH Guyatt, EJ MillsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.